Rhopressa
Aerie’s glaucoma drug gets strong preliminary FDA opinion
October 12, 2017Sales and Marketing Aerie, Aerie Pharmaceutical, FDA, Glaucoma, Rhopressa, pharma
In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively …
Latest content
October 28, 2026
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
